Interestingly, the patients with PIK3CA mutation identified in the metastatic tissue but in whom similar mutations could not be detected in corresponding serum ctDNA all had nonvisceral metastatic disease, suggesting that the location of the metastasis, in addition to size, may influence the amount of tumor DNA shed into the circulation. The gene discussed is PIK3CA; the disease is metastatic neoplasm.